Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-26
2005-07-26
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S025000
Reexamination Certificate
active
06921775
ABSTRACT:
Methods are disclosed for modulating brain damage mediated by non-NMDA ionotropic glutamate receptor antagonists, as topiramate, in conditions such as periventricular leukomalacia, cerebral palsy, mental retardation and neonatal stroke.
REFERENCES:
patent: 5438130 (1995-08-01), Goldin et al.
patent: 5506231 (1996-04-01), Lipton
patent: 6495601 (2002-12-01), Hochman
Pellock et al., Mental Retardation and Developmental Disabilities Research Reviews (2000) 6/4 (309-323) (abstract).
Follett Pamela L.
Jensen Frances E.
Volpe Joseph
Children's Medical Center Corporation
Elrifi Ivor R.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Spivack Phyllis G.
Triano, III Nicholas P.
LandOfFree
Methods for modulating brain damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for modulating brain damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for modulating brain damage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3382378